Concepedia

Mohamed Altai

MA

39

Publications

1.3K

Citations

25

H-Index

2011

Active since

Affiliations

Uppsala University(Current)

KTH Royal Institute of Technology

Science for Life Laboratory

Uppsala University Hospital

National Research Tomsk State University

Mohamed Altai is an author at Uppsala University specializing in medicine, molecular imaging, and drug discovery.

ORCID

Top concepts

Publications per year

2011–2020

39

Publications

39

The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a 68Ga-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin

Zohreh Varasteh, Ulrika Rosenström, Irina Velikyan et al. · Molecules · 2014 · 75 citations · Full text

, , +22

HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled Affibody Molecules

Camilla Hofström, Mohamed Altai, Hadis Honarvar et al. · Journal of Medicinal Chemistry · 2013 · 64 citations · Full text

Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors

Mohamed Altai, Hao Liu, Haozhong Ding et al. · Journal of Controlled Release · 2018 · 62 citations

, , +12

Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with <sup>99m</sup>Tc, <sup>111</sup>In, and <sup>125</sup>I

Camilla Hofström, Anna Orlova, Mohamed Altai et al. · Journal of Medicinal Chemistry · 2011 · 60 citations

Feasibility of Affibody-Based Bioorthogonal Chemistry–Mediated Radionuclide Pretargeting

Mohamed Altai, Anna Perols, Maria Tsourma et al. · Journal of Nuclear Medicine · 2015 · 59 citations · Full text

Rows per page

1–5 of 39